More than one million additional women could receive life-saving cervical-cancer checks if the NHS adopts self-testing, according to researchers at King’s College London. Their self-testing trial, deemed “fantastic” for empowering women, involved kits similar to Covid swabs that are sent to labs for analysis. The NHS is considering rolling out the scheme following the trial’s positive results. Currently, 4.6 million women in England avoid cervical-cancer screening due to discomfort, embarrassment, or fear. The YouScreen trial offered self-testing kits to women overdue for screening, either through their GP or by mail, leading to a significant increase in participation. If replicated nationwide, the screening rate could rise from 69.9% to 77.3%, reaching one million extra women over three years. The trial, conducted in five London boroughs, showed self-testing was effective across different ethnicities and socioeconomic groups. NHS England is now assessing the feasibility of wider implementation.
2 Likes
That’s amazing news! The self-testing option sounds like it could make such a difference for so many women. Do you know when the NHS might decide whether to roll this out nationwide? And are there any plans to address any potential challenges with distributing and processing so many self-test kits?